혈당 모니터링 기기 세계 시장 규모는 2022년 125억 달러로 평가되었습니다. 2023년 135억 4,000만 달러에서 2031년 237억 7,000만 달러로 성장하고, 예측 기간(2024-2031년) 동안 8.30%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.
혈당 모니터링(BGM) 시장은 효과적인 당뇨병 관리에 대한 수요 증가로 인해 괄목할 만한 성장세를 보이고 있으며, BGM 기기는 당뇨병 환자가 혈당 측정기를 사용하여 혈당 수치를 모니터링하고 식단, 인슐린 용량, 운동량에 대한 정보에 입각한 의사결정을 내릴 수 있게 해줍니다. 의사결정을 내릴 수 있게 해줍니다. 자가 혈당 측정(SMBG) 기술을 활용하면 환자는 모세혈관 포도당 농도를 즉시 정확하게 측정할 수 있어 저혈당, 고혈당 등의 상태를 신속하게 진단할 수 있습니다. 이러한 기술적 진보는 환자의 권한 부여와 자기 관리를 강화할 뿐만 아니라 더 건강한 생활 방식을 선택할 수 있도록 돕습니다. 다양한 모양, 크기, 가격대의 혈당 측정기가 판매되면서 당뇨병 관리 솔루션의 중요성에 대한 인식이 높아지고 있습니다. 이러한 소비자 인식 증가는 특히 당뇨병 모니터링 기기에 대한 접근성이 낮은 미개척 지역에서 큰 시장 기회를 창출할 것으로 예상됩니다. 미국의 자가 혈당 측정기 시장은 더 나은 혈당 조절과 혁신적인 관리 솔루션에 대한 지속적인 수요에 힘입어 지속적인 성장을 이룰 것으로 예상됩니다. 당뇨병 유병률이 계속 증가함에 따라 BGM 시장은 첨단 기술의 통합과 당뇨병 치료에 대한 환자 니즈에 대한 깊은 이해를 바탕으로 확장할 수 있는 전략적 입지를 확보할 수 있습니다.
Global Blood Glucose Monitoring Devices Market size was valued at USD 12.50 billion in 2022 and is poised to grow from USD 13.54 billion in 2023 to USD 23.77 billion by 2031, growing at a CAGR of 8.30% during the forecast period (2024-2031).
The blood glucose monitoring (BGM) market is experiencing notable growth driven by the increasing demand for effective diabetes management. BGM devices enable individuals with diabetes to monitor their blood glucose levels using a glucose meter, allowing them to make informed decisions about their diet, insulin dosage, and physical activity. By utilizing self-monitoring blood glucose (SMBG) technology, patients can instantly obtain accurate readings of their capillary glucose concentration, facilitating rapid diagnosis of conditions such as hypoglycemia and hyperglycemia. This technological advancement not only enhances patient empowerment and self-care but also encourages healthier lifestyle choices. With a diverse range of glucose meters available in various shapes, sizes, and price points, there is a growing awareness of the importance of diabetes management solutions. This increasing consumer awareness is expected to fuel significant market opportunities, especially in underserved areas where diabetes monitoring devices are least accessible. The market for self-monitoring blood glucose devices in the U.S. is projected to achieve sustainable growth, driven by the ongoing demand for better glycemic control and innovative management solutions. As the prevalence of diabetes continues to rise, the BGM market strategically positions itself for expansion, supported by the integration of advanced technology and a deeper understanding of patient needs in diabetes care.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Glucose Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Blood Glucose Monitoring Devices Market Segmental Analysis
Global Blood Glucose Monitoring Devices Market is segmented by Product, Application, and region. Based on Product, the market is segmented into Blood Glucose Monitors, Glucose Monitoring Strips, and Lancets. Based on Application, the market is segmented into Hospitals and Clinics, Diagnostic Centers, and Home Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Driver of the Global Blood Glucose Monitoring Devices Market
The global Blood Glucose Monitoring Devices market is significantly driven by the alarming rise in diabetes prevalence, particularly among the aging population susceptible to the disease. With an estimated 537 million adults diagnosed globally, as reported by the International Diabetes Federation, countries like China, India, the United States, Brazil, and Mexico represent a staggering 51.6% of this demographic. Contributing factors such as rapid urbanization and increasingly sedentary lifestyles further exacerbate this public health concern. Additionally, heightened awareness about diabetes management and preventive care, along with continuous innovations in monitoring technology, is propelling market growth and driving the adoption of these essential devices.
Restraints in the Global Blood Glucose Monitoring Devices Market
The global blood glucose monitoring devices market faces significant restraints from the high costs associated with these devices and the inadequacy of reimbursements. In developing nations like China and India, the burden of purchasing blood glucose monitors and test strips falls solely on patients, leading to limited accessibility and affordability. In contrast, developed countries such as Canada and certain European nations impose restrictions on the number of annually provided test strips based on specific treatment plans, discouraging comprehensive monitoring for many patients. This situation ultimately curtails market growth, as patients often forego necessary monitoring due to financial constraints.
Market Trends of the Global Blood Glucose Monitoring Devices Market
The Global Blood Glucose Monitoring Devices market is experiencing significant growth driven by technological advancements and innovative solutions aimed at improving patient care. As medical device companies shift from traditional manufacturing to becoming problem solvers, the integration of cloud computing and the Internet of Things (IoT) is revolutionizing diabetes management. Cutting-edge devices, including non-invasive monitoring solutions utilizing radio frequency and multi-sensor technology, as well as optical methods for glucose measurement, enhance accuracy and user-friendliness. This trend towards more sophisticated and connected devices not only caters to the rising prevalence of diabetes but also supports real-time remote monitoring, thereby enhancing clinical outcomes and reducing healthcare costs.